|
Volumn 12, Issue 4, 2009, Pages 374-377
|
Clinical research of bevacizumab in combination with irinotecan, fluorouracil and leucovorin for advanced metastatic colorectal cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CAMPTOTHECIN;
DRUG DERIVATIVE;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
MONOCLONAL ANTIBODY;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CLINICAL TRIAL;
COLORECTAL TUMOR;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
MALE;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
COLORECTAL NEOPLASMS;
FEMALE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASM STAGING;
SURVIVAL RATE;
|
EID: 77953154720
PISSN: 16710274
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|